Antiemetics Market
Antiemetics Market Size, Share & Trends Analysis Report by Drug Class (5-HT3 receptor antagonists, Anticholinergics, Benzodiazepines, Cannabinoids, and Others), and by Application (Chemotherapy, Gastroenteritis, General Anesthetics, Pregnancy, and Others) Forecast Period (2026-2035)
Industry Overview
Global antiemetics market was valued at $7.7 billion in 2025 and is projected to reach $13.2 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. The global antiemetics market is experiencing steady expansion, supported by the rising prevalence of cancer therapies, increasing surgical procedures, and greater clinical attention to nausea and vomiting management across multiple care settings. Advancements in pharmacological formulations and improved treatment protocols have enhanced therapeutic outcomes, encouraging broader adoption across both acute and chronic indications. Additionally, growing healthcare access in emerging economies and consistent demand from hospital and outpatient settings continue to reinforce market momentum through the forecast period.
Market Dynamics
Rising Demand for Supportive Care Therapies
The global antiemetics market is expanding as supportive care becomes an integral part of modern treatment protocols, particularly in oncology and surgical settings. Increased use of chemotherapy, complex anaesthesia procedures, and standardized post-operative care has elevated the clinical importance of effective nausea and vomiting control. This has led to consistent demand for established antiemetic drug classes across hospital and specialty care environments.
Product Optimization and Therapeutic Differentiation
Market growth is also influenced by ongoing optimization of existing drug formulations and clearer differentiation among therapeutic options. Pharmaceutical companies are focusing on improving dosing convenience, safety profiles, and indication-specific usage to strengthen product positioning. These efforts support sustained adoption while reinforcing the role of antiemetics as essential adjunct therapies across diverse medical applications.
Market Segmentation
- Based on the drug class, the market is segmented into 5-HT3 receptor antagonists, anticholinergics, benzodiazepines, cannabinoids, and others.
- Based on the application, the market is segmented into chemotherapy, gastroenteritis, general anesthetics, pregnancy, and others.
5-HT3 Receptor Antagonists Segment to Lead the Market with the Largest Share
5-HT3 receptor antagonists represent the leading drug class within the global antiemetics market due to their proven efficacy in preventing and treating nausea and vomiting associated with chemotherapy, radiotherapy, and surgical procedures. These agents are widely prescribed in hospital and oncology settings as part of standard supportive care protocols, supported by strong clinical evidence and broad regulatory approvals. Their established safety profile, availability in both branded and generic forms, and compatibility with combination therapies continue to drive sustained demand across developed and emerging healthcare markets.
Chemotherapy: A Key Segment in Market Growth
Chemotherapy remains the dominant application segment for antiemetics, driven by the high incidence of treatment-induced nausea and vomiting among cancer patients. Effective antiemetic management is considered essential for improving patient adherence to chemotherapy regimens and maintaining quality of life. As global cancer prevalence rises and access to oncology treatments expands, the consistent need for antiemetic support in both inpatient and outpatient chemotherapy settings continues to underpin growth in this segment.
Regional Outlook
The global antiemetics market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region Dominates the Market with a Major Share
North America represents a leading region in the global antiemetics market, supported by advanced healthcare infrastructure, high adoption of chemotherapy and surgical procedures, and strong adherence to clinical treatment guidelines. The presence of major pharmaceutical manufacturers, widespread availability of branded and generic antiemetic drugs, and favorable reimbursement frameworks further contribute to sustained market demand across hospital and outpatient care settings.
Asia-Pacific Region to Provide Lucrative Market Growth
Asia-Pacific is a rapidly growing region in the global antiemetics market, driven by expanding healthcare access, rising cancer incidence, and increasing use of modern medical treatments. Improvements in hospital infrastructure, growing awareness of supportive care therapies, and the availability of cost-effective generic formulations are strengthening market penetration across both urban and semi-urban healthcare facilities in the region.
Market Players Outlook
The major companies operating in the global antiemetics market include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., and Novartis AG, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In August 2024, Amneal Pharmaceuticals, Inc. partnered with Steriscience to launch a ready-to-use injectable formulation of fosaprepitant (Focinvez) for patients receiving highly or moderately emetogenic chemotherapy. The single-dose vial, manufactured by Steriscience and developed with SPES Pharmaceuticals, is free from Polysorbate 80, does not require reconstitution or dilution, and is designed to simplify administration while preventing acute and delayed chemotherapy-induced nausea and vomiting in both adult and pediatric patients.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global antiemetics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Antiemetics Market Sales Analysis – Drug Class | Application ($ Million)
- Antiemetics Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Antiemetics Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Antiemetics Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Antiemetics Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Antiemetics Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Antiemetics Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Antiemetics Market Revenue and Share by Manufacturers
- Antiemetics Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- GlaxoSmithKline plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson Services, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck & Co., Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Novartis AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- GlaxoSmithKline plc
- Key Company Analysis
- Global Antiemetics Market Sales Analysis by Drug Class ($ Million)
- 5-HT3 Receptor Antagonists
- Anticholinergics
- Benzodiazepines
- Cannabinoids
- Others
- Global Antiemetics Market Sales Analysis by Application ($ Million)
- Chemotherapy
- Gastroenteritis
- General Anesthetics
- Pregnancy
- Others
- Regional Analysis
- North American Antiemetics Market Sales Analysis – Drug Class | Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Antiemetics Market Sales Analysis – Drug Class | Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Antiemetics Market Sales Analysis – Drug Class | Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Others)
- Rest of Asia-Pacific
- Rest of the World Antiemetics Market Sales Analysis – Drug Class | Application | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Astellas Pharma Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AstraZeneca plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bristol-Myers Squibb Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cadila Pharmaceuticals Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Daiichi Sankyo Company, Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Reddy’s Laboratories Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eagle Pharmaceuticals, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eisai Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GlaxoSmithKline plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Helsinn Healthcare SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Heron Therapeutics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hikma Pharmaceuticals PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ipca Laboratories Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Services, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kyowa Kirin Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Novartis AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Astellas Pharma Inc.
1. Global Antiemetics Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
2. Global 5-HT3 Receptor Antagonists Antiemetics Market Research And Analysis By Region, 2025-2035 ($ Million)
3. Global Anticholinergics Antiemetics Market Research And Analysis By Region, 2025-2035 ($ Million)
4. Global Benzodiazepines Antiemetics Market Research And Analysis By Region, 2025-2035 ($ Million)
5. Global Cannabinoids Antiemetics Market Research And Analysis By Region, 2025-2035 ($ Million)
6. Global Others Antiemetics Market Research And Analysis By Region, 2025-2035 ($ Million)
7. Global Antiemetics Market Research And Analysis By Application, 2025-2035 ($ Million)
8. Global Antiemetics For Chemotherapy Market Research And Analysis By Region, 2025-2035 ($ Million)
9. Global Antiemetics For Gastroenteritis Market Research And Analysis By Region, 2025-2035 ($ Million)
10. Global Antiemetics For General Anesthetics Market Research And Analysis By Region, 2025-2035 ($ Million)
11. Global Antiemetics For Pregnancy Market Research And Analysis By Region, 2025-2035 ($ Million)
12. Global Antiemetics For Others Market Research And Analysis By Region, 2025-2035 ($ Million)
13. Global Antiemetics Market Research And Analysis By Geography, 2025-2035 ($ Million)
14. North American Antiemetics Market Research And Analysis By Country, 2025-2035 ($ Million)
15. North American Antiemetics Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
16. North American Antiemetics Market Research And Analysis By Application, 2025-2035 ($ Million)
17. European Antiemetics Market Research And Analysis By Country, 2025-2035 ($ Million)
18. European Antiemetics Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
19. European Antiemetics Market Research And Analysis By Application, 2025-2035 ($ Million)
20. Asia-Pacific Antiemetics Market Research And Analysis By Country, 2025-2035 ($ Million)
21. Asia-Pacific Antiemetics Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
22. Asia-Pacific Antiemetics Market Research And Analysis By Application, 2025-2035 ($ Million)
23. Rest Of The World Antiemetics Market Research And Analysis By Country, 2025-2035 ($ Million)
24. Rest Of The World Antiemetics Market Research And Analysis By Drug Class, 2025-2035 ($ Million)
25. Rest Of The World Antiemetics Market Research And Analysis By Application, 2025-2035 ($ Million)
1. Global Antiemetics Market Share By Drug Class, 2025 Vs 2035 (%)
2. Global 5-HT3 Receptor Antagonists Antiemetics Market Share By Region, 2025 Vs 2035 (%)
3. Global Anticholinergics Antiemetics Market Share By Region, 2025 Vs 2035 (%)
4. Global Benzodiazepines Antiemetics Market Share By Region, 2025 Vs 2035 (%)
5. Global Cannabinoids Antiemetics Market Share By Region, 2025 Vs 2035 (%)
6. Global Others Antiemetics Market Share By Region, 2025 Vs 2035 (%)
7. Global Antiemetics Market Share By Application, 2025 Vs 2035 (%)
8. Global Antiemetics For Chemotherapy Market Share By Region, 2025 Vs 2035 (%)
9. Global Antiemetics For Gastroenteritis Market Share By Region, 2025 Vs 2035 (%)
10. Global Antiemetics For General Anesthetics Market Share By Region, 2025 Vs 2035 (%)
11. Global Antiemetics For Pregnancy Market Share By Region, 2025 Vs 2035 (%)
12. Global Antiemetics For Others Market Share By Region, 2025 Vs 2035 (%)
13. Global Antiemetics Market Share By Region, 2025 Vs 2035 (%)
14. US Antiemetics Market Size, 2025-2035 ($ Million)
15. Canada Antiemetics Market Size, 2025-2035 ($ Million)
16. UK Antiemetics Market Size, 2025-2035 ($ Million)
17. France Antiemetics Market Size, 2025-2035 ($ Million)
18. Germany Antiemetics Market Size, 2025-2035 ($ Million)
19. Italy Antiemetics Market Size, 2025-2035 ($ Million)
20. Spain Antiemetics Market Size, 2025-2035 ($ Million)
21. Russia Antiemetics Market Size, 2025-2035 ($ Million)
22. Rest Of Europe Antiemetics Market Size, 2025-2035 ($ Million)
23. India Antiemetics Market Size, 2025-2035 ($ Million)
24. China Antiemetics Market Size, 2025-2035 ($ Million)
25. Japan Antiemetics Market Size, 2025-2035 ($ Million)
26. South Korea Antiemetics Market Size, 2025-2035 ($ Million)
27. ASEAN Antiemetics Market Size, 2025-2035 ($ Million)
28. Australia and New Zealand Antiemetics Market Size, 2025-2035 ($ Million)
29. Rest Of Asia-Pacific Antiemetics Market Size, 2025-2035 ($ Million)
30. Latin America Antiemetics Market Size, 2025-2035 ($ Million)
31. Middle East And Africa Antiemetics Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Antiemetics Market in 2025 is estimated to be around $7.7 billion.
North America holds the largest share in the Antiemetics Market.
Leading players in the Antiemetics Market include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., and Novartis AG, among others.
The Antiemetics Market is expected to grow at a CAGR of 5.7% from 2026 to 2035.
The Antiemetics Market growth is driven by increasing prevalence of cancer and gastrointestinal disorders and rising demand for effective nausea and vomiting management therapies.
